Dynavax Technologies Company
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Investors
Founded Date:
1996-01-01
Total Funding:
1044500000
Employee Number:
501-1000
Funding Status:
IPO
Last Funding Type:
Post-IPO Debt
Investors Number:
21
Last Funding Date:
2021-05-11
Industry:
Tumor-Specific Antigens
Headquarters:
Berkeley, California, United States
Estimated Revenue:
$10M to $50M